Elonva Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Corifollitropin α

Indications/Uses

Controlled ovarian stimulation (COS) in combination w/ a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

Dosage/Direction for Use

SC Administer Elonva on stimulation day 1, followed by a GnRH antagonist on day 5 or 6. Treatment may be continued w/ daily inj of recombinant FSH on day 8. Women >36 yr weighing ≥50 kg or >60 kg regardless of age 150 mcg as single dose, ≤36 yr weighing ≤60 kg 100 mcg as single dose.

Contraindications

Hypersensitivity. Ovarian, breast, uterine, pituitary or hypothalamic tumours. Abnormal vag bleeding w/o known diagnosed cause. Primary ovarian failure. Ovarian cysts or enlarged ovaries. History of ovarian hyperstimulation syndrome (OHSS); previous COS cycle resulted in >30 follicles ≥11 mm measured by ultrasound exam; basal antral follicle count >20; polycystic ovarian syndrome. Uterine fibroid tumours & reproductive organ malformations incompatible w/ pregnancy. Pregnancy.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

G03GA09 - corifollitropin alfa ; Belongs to the class of gonadotropins. Used as ovulation stimulants.

Regulatory Classification

POM

Presentation/Packing

Form

Elonva soln for inj 100 mcg/0.5 mL

Packing/Price

1's

Form

Elonva soln for inj 150 mcg/0.5 mL

Packing/Price

1's

Elonva

corifollitropin alfa

Manufacturer:

Organon